Immunology

Step 1: Evaluate Statement 1
Statement 1: "The time lag between the HIV infection and AIDS manifestation varies from 2-3 weeks."
This statement is incorrect. The time lag between HIV infection and AIDS manifestation, also called the "window period," usually ranges from a few years to a decade or more. It is not as short as 2-3 weeks.

Step 2: Evaluate Statement 2
Statement 2: "After entering the body, HIV enters B-lymphocytes."
This statement is also incorrect. HIV primarily targets CD4+ T-lymphocytes, not B-lymphocytes. The virus binds to the CD4 receptor on the surface of T-helper cells, which is the primary host for HIV. It does not enter B-lymphocytes as the main mechanism of infection.

Step 3: Evaluate Statement 3
Statement 3: "The AIDS-affected individuals are more susceptible to Tuberculosis."
This statement is correct. HIV/AIDS compromises the immune system, particularly the CD4+ T-cells. This weakened immune system makes individuals more susceptible to opportunistic infections, including Tuberculosis (TB). TB is one of the leading causes of death among people living with HIV due to the weakened immune defenses.

Step 4: Evaluate Statement 4
Statement 4: "HIV infection depletes only the CD8 lymphocytes in the body."
This statement is incorrect. HIV primarily targets CD4+ T-lymphocytes, not CD8+ T-cells. CD8+ T-cells are important in the immune response, but they are not the main target of HIV. The depletion of CD4+ T-cells leads to the weakening of the immune system, which is characteristic of AIDS.

Conclusion
The correct answer is statement (3), which accurately reflects the increased susceptibility of AIDS-affected individuals to Tuberculosis. HIV compromises the immune system, making the body more prone to opportunistic infections like TB.

Cyclosporin A is a well-known immunosuppressive drug used primarily in organ transplantation to prevent rejection. It is obtained from the fungus Trichoderma polysporum.
Cholesterol is not an immunosuppressant and is obtained from animal sources or synthesized in the body.
Streptokinase is a clot-dissolving enzyme used in the treatment of myocardial infarction, and is derived from Streptococcus species.
Botulinum toxin is a neurotoxin used in small doses for cosmetic and neurological treatments, and is derived from Clostridium botulinum. However, it is not primarily classified as an immunosuppressant.

Step 1: Understanding Western blot technique.
Western blotting is a widely used analytical technique to detect specific proteins (including antibodies) in a sample. It uses a combination of gel electrophoresis and specific antibody binding.
Step 2: Application to antibodies.
In infected patients, antibodies generated in response to pathogens can be identified by using antigen-coated membranes in Western blot, followed by enzyme-linked secondary antibody detection.
Step 3: Eliminate other options.
ELISPOT is used to measure cytokine secretion or specific cell responses, not circulating antibodies.
PCR detects DNA or RNA, not proteins.
Northern blot is for RNA detection.

Step 1: Understanding the antibody types.
Immunoglobulins (Ig) are antibodies that play critical roles in the immune system by identifying and neutralizing foreign objects like bacteria, viruses, and toxins. Each class of immunoglobulin has a specific function:

• IgG: The most abundant antibody in blood and extracellular fluid, primarily involved in systemic immune responses and protection against bacterial and viral infections.
• IgD: Found on the surface of immature B cells, it plays a role in initiating immune responses but is not primarily responsible for protecting against pathogens in the respiratory or digestive systems.
• IgM: The first antibody produced during the initial immune response. It is mainly found in the blood and is efficient at activating the complement system.
• IgA: This antibody is found in mucosal areas such as the respiratory and gastrointestinal tracts. It provides protection against inhaled and ingested pathogens by neutralizing them before they can invade the body’s cells.

Step 2: Conclusion.
IgA is the antibody type that provides immunity in mucosal surfaces such as the respiratory and gastrointestinal tracts, where it protects against inhaled and ingested pathogens. Therefore, the correct answer is IgA.

Step 1: Understanding MHC class II molecules.
MHC class II molecules are crucial components of the immune system. They present foreign peptides to T-cells, allowing the immune system to recognize and respond to pathogens. These peptides are processed and bound to MHC class II molecules in antigen-presenting cells (APCs) like dendritic cells, macrophages, and B-cells.

Step 2: Peptide length for MHC class II.
Peptides that bind to MHC class II molecules are typically in the range of 15 to 20 amino acids. These peptides are recognized by helper T-cells to initiate an immune response.

Step 3: Discarding other options.

• Option 1 (8-11 amino acids): ❌ This peptide length is typical of peptides that bind to MHC class I molecules, not MHC class II.
• Option 2 (21-27 amino acids): ❌ This peptide length is too long for MHC class II molecules, as they typically bind peptides within the 15-20 amino acid range.
• Option 4 (507 amino acids): ❌ This peptide length is far too large. Peptides presented by MHC molecules are typically in the range of a few dozen amino acids.

Step 4: Conclusion.
Therefore, the correct peptide length for MHC class II molecules is 15-20 amino acids.

Step 1: Understand the concept of antibody diversity.
Antibody diversity refers to the wide variety of antibodies produced by the immune system to recognize different antigens. This diversity allows the immune system to effectively defend against various pathogens.

Step 2: Mechanisms contributing to antibody diversity.

• Gene rearrangement: ✅ Correct. Gene rearrangement (V(D)J recombination) is the primary mechanism that generates antibody diversity by recombining gene segments in the immunoglobulin genes, allowing for the creation of antibodies with different specificities.
• Domain swapping: ❌ Domain swapping is not involved in antibody diversity. It pertains to protein interactions but not to the generation of diverse antibodies.
• Post-translational modification: ❌ Post-translational modifications modify the structure of antibodies after synthesis but do not contribute to the diversity of antibodies.
• Proteolytic processing: ❌ Proteolytic processing involves the cleavage of proteins but does not play a significant role in generating antibody diversity.

Step 3: Conclusion.
The mechanism responsible for antibody diversity is gene rearrangement (V(D)J recombination), which enables the immune system to produce a wide array of antibodies with different specificities for diverse antigens.

Correct Answer: Gene rearrangement

Step 1: Understand the structure of an antibody.
Antibodies (immunoglobulins) are Y-shaped molecules composed of two identical heavy chains and two identical light chains. Each chain has a variable region (for antigen binding) and a constant region (for effector function). The variable regions determine antigen specificity.

Step 2: Examine the regions of the antibody.

• Light chain variable region: ✅ Correct. This region binds directly to the antigen and determines the antibody's specificity.
• Light chain constant region: ❌ Plays a role in structure and isotype function, not antigen specificity.
• Heavy chain constant region: ❌ Involved in effector functions (e.g., complement activation), not in antigen recognition.
• Hinge region: ❌ Provides flexibility to the antibody but does not determine antigen specificity.

Step 3: Conclusion.
The specificity of an antibody is primarily determined by the light chain variable region, as it directly participates in recognizing and binding to specific antigens.

Correct Answer: Option (1)

Step 1: Understand allergic immune response.
An allergic immune response occurs when the immune system misidentifies a harmless substance (allergen) as a threat and mounts a defense against it. This leads to inflammation, itching, and other symptoms associated with allergies.

Step 2: Evaluate the antibodies involved in allergies.

• IgE: ✅ Correct. IgE is the key antibody in allergies. It binds to allergens and triggers mast cells and basophils to release histamine and other inflammatory chemicals.
• IgA: ❌ Involved in mucosal immunity (e.g., gut, saliva, tears), not typically linked with allergic reactions.
• IgG: ❌ Important for long-term immunity and pathogen neutralization but not primarily responsible for allergic symptoms.
• IgM: ❌ First antibody produced in primary immune response, not directly involved in allergic responses.

Step 3: Conclusion.
The antibody that plays the most important role in allergic immune responses is IgE.

Correct Answer: Option (1)

Step 1: Understand Regulatory B cells (Bregs).
Regulatory B cells (Bregs) are a specialized subset of B-cells that help control immune responses and maintain immune system balance. They play a vital role in suppressing inflammation and preventing autoimmune reactions.

Step 2: Evaluate the cytokines involved in Breg function.

• IL-10: Correct. IL-10 is the signature cytokine of Bregs. It inhibits the function of pro-inflammatory cells such as Th1, Th17, and antigen-presenting cells. IL-10 is central to the immune-suppressive activity of Bregs.
• IL-2: Involved in T-cell proliferation and function. Not secreted by Bregs.
• TNF-alpha: A pro-inflammatory cytokine secreted mainly by macrophages and T-cells. Not characteristic of Bregs.
• IFN-gamma: Produced by T-cells and NK cells to activate macrophages and promote inflammation. Not a Breg cytokine.

Step 3: Conclusion.
Regulatory B cells exert their immune-suppressive effects primarily through the secretion of IL-10.

Correct Answer: Option (1)

Step 1: Understand Myasthenia Gravis.
Myasthenia gravis is an autoimmune neuromuscular disorder. In this condition, the immune system produces antibodies that interfere with the communication between nerves and muscles, causing weakness and fatigue in skeletal muscles.

Step 2: Evaluate the options:

• Acetylcholine receptor protein: Correct. This is the primary target in Myasthenia gravis. Autoantibodies block or destroy acetylcholine receptors at the neuromuscular junction, preventing effective signal transmission.
• NOD1 protein: Involved in detecting bacterial components and activating innate immunity. Not involved in Myasthenia gravis.
• TLR11 protein: A toll-like receptor involved in pathogen recognition, primarily in mice. Not related to Myasthenia gravis.
• RIG-I protein: A receptor involved in recognizing viral RNA. Not associated with Myasthenia gravis.

Step 3: Conclusion.
The correct target of autoantibodies in Myasthenia gravis is the Acetylcholine receptor protein.

Correct Answer: Option (1)

Step 1: Understand the role of immunoglobulins.
Immunoglobulins (antibodies) are essential components of the immune system. During pregnancy, maternal antibodies provide passive immunity to the fetus. This protection is critical before the fetus's own immune system becomes fully functional.

Step 2: Evaluate the immunoglobulins:

• IgM: First antibody produced in response to infection, does not cross the placenta due to its large pentameric structure.
• IgG: The only immunoglobulin that crosses the placenta. It provides systemic passive immunity to the fetus.
• IgA: Found mainly in mucosal secretions (e.g., saliva, breast milk), does not cross the placenta.
• IgM and IgG (Option 2): Incorrect. Only IgG can cross the placenta.

Step 3: Conclusion.
The correct immunoglobulin that crosses the placenta and provides passive immunity to the fetus is IgG only.

Correct Answer: Option (4)

Step 1: Understand the role of CD4 antigen.
The CD4 antigen is a surface glycoprotein expressed primarily on helper T-cells. It assists in immune responses by binding to MHC class II molecules on antigen-presenting cells, facilitating T-cell activation and coordination of the adaptive immune response.

Step 2: Evaluate which cells express CD4.

• B-cells: Do not express CD4. They are identified by markers such as CD19 and CD20 and are mainly involved in antibody production.
• T-cells: CD4 is expressed on helper T-cells (a subset of T-cells). These are central to activating other immune cells.
• Macrophage cells: While macrophages interact with CD4+ T-cells, they do not express CD4 themselves.
• Gamma-delta T-cells: These T-cells have a distinct receptor and do not express CD4.

Step 3: Conclusion.
The CD4 antigen is absent on B-cells. Therefore, the correct answer is Option (1): B-cells.